Global Therapeutic Nuclear Medicines Market Growth 2021-2026

  • receipt Report ID : 161125
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 164
  • list Medical Devices
Buy @ $3660

According to this latest study, the 2020 growth of Therapeutic Nuclear Medicines will have significant change from previous year. By the most conservative estimates of global Therapeutic Nuclear Medicines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1005.5 million in 2019. Over the next five years the Therapeutic Nuclear Medicines market will register a 14.3% CAGR in terms of revenue, the global market size will reach US$ 1717.1 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Radium-223

Lutetium-177

Iodine-131

Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Thyroid

Bone Metastasis

Lymphoma

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Therapeutic Nuclear Medicines Consumption 2016-2026

2.1.2 Therapeutic Nuclear Medicines Consumption CAGR by Region

2.2 Therapeutic Nuclear Medicines Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Therapeutic Nuclear Medicines Sales by Type

2.3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)

2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2016-2021)

2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2016-2021)

2.4 Therapeutic Nuclear Medicines Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Therapeutic Nuclear Medicines Sales by Application

2.5.1 Global Therapeutic Nuclear Medicines Sale Market Share by Application (2016-2021)

2.5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Application (2016-2021)

2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2016-2021)

3 Global Therapeutic Nuclear Medicines by Company

3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Company

3.1.1 Global Therapeutic Nuclear Medicines Sales by Company (2019-2021)

3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Company (2019-2021)

3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company

3.2.1 Global Therapeutic Nuclear Medicines Revenue by Company (2019-2021)

3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2019-2021)

3.3 Global Therapeutic Nuclear Medicines Sale Price by Company

3.4 Global Manufacturers Therapeutic Nuclear Medicines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Therapeutic Nuclear Medicines Product Location Distribution

3.4.2 Players Therapeutic Nuclear Medicines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Nuclear Medicines by Region

4.1 Global Therapeutic Nuclear Medicines by Region

4.1.1 Global Therapeutic Nuclear Medicines Sales by Region

4.1.2 Global Therapeutic Nuclear Medicines Revenue by Region

4.2 Americas Therapeutic Nuclear Medicines Sales Growth

4.3 APAC Therapeutic Nuclear Medicines Sales Growth

4.4 Europe Therapeutic Nuclear Medicines Sales Growth

4.5 Middle East & Africa Therapeutic Nuclear Medicines Sales Growth

5 Americas

5.1 Americas Therapeutic Nuclear Medicines Sales by Country

5.1.1 Americas Therapeutic Nuclear Medicines Sales by Country (2016-2021)

5.1.2 Americas Therapeutic Nuclear Medicines Revenue by Country (2016-2021)

5.2 Americas Therapeutic Nuclear Medicines Sales by Type

5.3 Americas Therapeutic Nuclear Medicines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Therapeutic Nuclear Medicines Sales by Region

6.1.1 APAC Therapeutic Nuclear Medicines Sales by Region (2016-2021)

6.1.2 APAC Therapeutic Nuclear Medicines Revenue by Region (2016-2021)

6.2 APAC Therapeutic Nuclear Medicines Sales by Type

6.3 APAC Therapeutic Nuclear Medicines Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Therapeutic Nuclear Medicines by Country

7.1.1 Europe Therapeutic Nuclear Medicines Sales by Country (2016-2021)

7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2016-2021)

7.2 Europe Therapeutic Nuclear Medicines Sales by Type

7.3 Europe Therapeutic Nuclear Medicines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Therapeutic Nuclear Medicines by Country

8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2016-2021)

8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2016-2021)

8.2 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type

8.3 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Therapeutic Nuclear Medicines Distributors

10.3 Therapeutic Nuclear Medicines Customer

11 Global Therapeutic Nuclear Medicines Market Forecast

11.1 Global Therapeutic Nuclear Medicines Forecast by Region

11.1.1 Global Therapeutic Nuclear Medicines Forecast by Regions (2021-2026)

11.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Therapeutic Nuclear Medicines Forecast by Type

11.7 Global Therapeutic Nuclear Medicines Forecast by Application

12 Key Players Analysis

12.1 Novartis AG

12.1.1 Novartis AG Novartis AG Company Information

12.1.2 Novartis AG Therapeutic Nuclear Medicines Product Offered

12.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Novartis AG Main Business Overview

12.1.5 Novartis AG Latest Developments

12.2 Bayer

12.2.1 Bayer Company Information

12.2.2 Bayer Therapeutic Nuclear Medicines Product Offered

12.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Bayer Main Business Overview

12.2.5 Bayer Latest Developments

12.3 China Isotope & Radiation

12.3.1 China Isotope & Radiation Company Information

12.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Offered

12.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 China Isotope & Radiation Main Business Overview

12.3.5 China Isotope & Radiation Latest Developments

12.4 Q BioMed

12.4.1 Q BioMed Company Information

12.4.2 Q BioMed Therapeutic Nuclear Medicines Product Offered

12.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Q BioMed Main Business Overview

12.4.5 Q BioMed Latest Developments

12.5 Curium Pharmaceuticals

12.5.1 Curium Pharmaceuticals Company Information

12.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

12.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Curium Pharmaceuticals Main Business Overview

12.5.5 Curium Pharmaceuticals Latest Developments

12.6 Jubilant DraxImage

12.6.1 Jubilant DraxImage Company Information

12.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Offered

12.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Jubilant DraxImage Main Business Overview

12.6.5 Jubilant DraxImage Latest Developments

12.7 Dongcheng

12.7.1 Dongcheng Company Information

12.7.2 Dongcheng Therapeutic Nuclear Medicines Product Offered

12.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Dongcheng Main Business Overview

12.7.5 Dongcheng Latest Developments

12.8 Lantheus

12.8.1 Lantheus Company Information

12.8.2 Lantheus Therapeutic Nuclear Medicines Product Offered

12.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Lantheus Main Business Overview

12.8.5 Lantheus Latest Developments

12.9 Acrotech Biopharma.

12.9.1 Acrotech Biopharma. Company Information

12.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Offered

12.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Acrotech Biopharma. Main Business Overview

12.9.5 Acrotech Biopharma. Latest Developments

12.10 Progenics Pharmaceuticals

12.10.1 Progenics Pharmaceuticals Company Information

12.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

12.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Progenics Pharmaceuticals Main Business Overview

12.10.5 Progenics Pharmaceuticals Latest Developments

12.11 International Isotopes

12.11.1 International Isotopes Company Information

12.11.2 International Isotopes Therapeutic Nuclear Medicines Product Offered

12.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 International Isotopes Main Business Overview

12.11.5 International Isotopes Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Therapeutic Nuclear Medicines Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Radium-223

Table 3. Major Players of Lutetium-177

Table 4. Major Players of Iodine-131

Table 5. Major Players of Other

Table 6. Global Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)

Table 7. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)

Table 8. Global Therapeutic Nuclear Medicines Revenue by Type (2016-2021) & ($ million)

Table 9. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2021)

Table 10. Global Therapeutic Nuclear Medicines Sale Price by Type (2016-2021)

Table 11. Global Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)

Table 12. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)

Table 13. Global Therapeutic Nuclear Medicines Value by Application (2016-2021)

Table 14. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2016-2021)

Table 15. Global Therapeutic Nuclear Medicines Sale Price by Application (2016-2021)

Table 16. Global Therapeutic Nuclear Medicines Sales by Company (2019-2021) & (K Units)

Table 17. Global Therapeutic Nuclear Medicines Sales Market Share by Company (2019-2021)

Table 18. Global Therapeutic Nuclear Medicines Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2019-2021)

Table 20. Global Therapeutic Nuclear Medicines Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Therapeutic Nuclear Medicines Producing Area Distribution and Sales Area

Table 22. Players Therapeutic Nuclear Medicines Products Offered

Table 23. Therapeutic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Therapeutic Nuclear Medicines Sales by Region (2016-2021) (K Units)

Table 27. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)

Table 28. Global Therapeutic Nuclear Medicines Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2021)

Table 30. Americas Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)

Table 31. Americas Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)

Table 32. Americas Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)

Table 34. Americas Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)

Table 35. Americas Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)

Table 36. Americas Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)

Table 37. Americas Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)

Table 38. APAC Therapeutic Nuclear Medicines Sales by Region (2016-2021) & (K Units)

Table 39. APAC Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2021)

Table 40. APAC Therapeutic Nuclear Medicines Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2021)

Table 42. APAC Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)

Table 43. APAC Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)

Table 44. APAC Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)

Table 45. APAC Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)

Table 46. Europe Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)

Table 47. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)

Table 48. Europe Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)

Table 50. Europe Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)

Table 51. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)

Table 52. Europe Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)

Table 53. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2016-2021) & (K Units)

Table 55. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2016-2021) & (K Units)

Table 59. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2016-2021) & (K Units)

Table 61. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)

Table 62. Global Therapeutic Nuclear Medicines Sales Forecast by Type (2021-2026) & (K Units)

Table 63. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2021-2026)

Table 64. Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 65. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2021-2026)

Table 66. Global Therapeutic Nuclear Medicines Sales Forecast by Application (2021-2026) & (K Units)

Table 67. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2021-2026)

Table 68. Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 69. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Application (2021-2026)

Table 70. Novartis AG Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 71. Novartis AG Therapeutic Nuclear Medicines Product Offered

Table 72. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 73. Novartis AG Main Business

Table 74. Novartis AG Latest Developments

Table 75. Bayer Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 76. Bayer Therapeutic Nuclear Medicines Product Offered

Table 77. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 78. Bayer Main Business

Table 79. Bayer Latest Developments

Table 80. China Isotope & Radiation Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 81. China Isotope & Radiation Therapeutic Nuclear Medicines Product Offered

Table 82. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 83. China Isotope & Radiation Main Business

Table 84. China Isotope & Radiation Latest Developments

Table 85. Q BioMed Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 86. Q BioMed Therapeutic Nuclear Medicines Product Offered

Table 87. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 88. Q BioMed Main Business

Table 89. Q BioMed Latest Developments

Table 90. Curium Pharmaceuticals Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 91. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

Table 92. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 93. Curium Pharmaceuticals Main Business

Table 94. Curium Pharmaceuticals Latest Developments

Table 95. Jubilant DraxImage Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 96. Jubilant DraxImage Therapeutic Nuclear Medicines Product Offered

Table 97. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 98. Jubilant DraxImage Main Business

Table 99. Jubilant DraxImage Latest Developments

Table 100. Dongcheng Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 101. Dongcheng Therapeutic Nuclear Medicines Product Offered

Table 102. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 103. Dongcheng Main Business

Table 104. Dongcheng Latest Developments

Table 105. Lantheus Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 106. Lantheus Therapeutic Nuclear Medicines Product Offered

Table 107. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 108. Lantheus Main Business

Table 109. Lantheus Latest Developments

Table 110. Acrotech Biopharma. Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 111. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Offered

Table 112. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 113. Acrotech Biopharma. Main Business

Table 114. Acrotech Biopharma. Latest Developments

Table 115. Progenics Pharmaceuticals Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 116. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

Table 117. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 118. Progenics Pharmaceuticals Main Business

Table 119. Progenics Pharmaceuticals Latest Developments

Table 120. International Isotopes Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 121. International Isotopes Therapeutic Nuclear Medicines Product Offered

Table 122. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 123. International Isotopes Main Business

Table 124. International Isotopes Latest Developments

List of Figures

Figure 1. Picture of Therapeutic Nuclear Medicines

Figure 2. Therapeutic Nuclear Medicines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Therapeutic Nuclear Medicines Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Therapeutic Nuclear Medicines Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Therapeutic Nuclear Medicines Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Radium-223

Figure 10. Product Picture of Lutetium-177

Figure 11. Product Picture of Iodine-131

Figure 12. Product Picture of Other

Figure 13. Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2020

Figure 14. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2021)

Figure 15. Therapeutic Nuclear Medicines Consumed in Thyroid

Figure 16. Global Therapeutic Nuclear Medicines Market: Thyroid (2016-2021) & (K Units)

Figure 17. Therapeutic Nuclear Medicines Consumed in Bone Metastasis

Figure 18. Global Therapeutic Nuclear Medicines Market: Bone Metastasis (2016-2021) & (K Units)

Figure 19. Therapeutic Nuclear Medicines Consumed in Lymphoma

Figure 20. Global Therapeutic Nuclear Medicines Market: Lymphoma (2016-2021) & (K Units)

Figure 21. Therapeutic Nuclear Medicines Consumed in Other

Figure 22. Global Therapeutic Nuclear Medicines Market: Other (2016-2021) & (K Units)

Figure 23. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)

Figure 24. Global Therapeutic Nuclear Medicines Revenue Market Share by Application in 2020

Figure 25. Global Therapeutic Nuclear Medicines Revenue Market by Company in 2020 ($ Million)

Figure 26. Global Therapeutic Nuclear Medicines Revenue Market Share by Company in 2020

Figure 27. Global Therapeutic Nuclear Medicines Sales Market Share by Regions (2016-2021)

Figure 28. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2020

Figure 29. Americas Therapeutic Nuclear Medicines Sales 2016-2021 (K Units)

Figure 30. Americas Therapeutic Nuclear Medicines Revenue 2016-2021 ($ Millions)

Figure 31. APAC Therapeutic Nuclear Medicines Sales 2016-2021 (K Units)

Figure 32. APAC Therapeutic Nuclear Medicines Revenue 2016-2021 ($ Millions)

Figure 33. Europe Therapeutic Nuclear Medicines Sales 2016-2021 (K Units)

Figure 34. Europe Therapeutic Nuclear Medicines Revenue 2016-2021 ($ Millions)

Figure 35. Middle East & Africa Therapeutic Nuclear Medicines Sales 2016-2021 (K Units)

Figure 36. Middle East & Africa Therapeutic Nuclear Medicines Revenue 2016-2021 ($ Millions)

Figure 37. Americas Therapeutic Nuclear Medicines Sales Market Share by Country in 2020

Figure 38. Americas Therapeutic Nuclear Medicines Revenue Market Share by Country in 2020

Figure 39. Americas Therapeutic Nuclear Medicines Sales Market Share by Type in 2020

Figure 40. Americas Therapeutic Nuclear Medicines Sales Market Share by Application in 2020

Figure 41. United States Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 42. Canada Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 43. Mexico Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 44. Brazil Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 45. APAC Therapeutic Nuclear Medicines Sales Market Share by Region in 2020

Figure 46. APAC Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2020

Figure 47. APAC Therapeutic Nuclear Medicines Sales Market Share by Type in 2020

Figure 48. APAC Therapeutic Nuclear Medicines Sales Market Share by Application in 2020

Figure 49. China Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 50. Japan Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 51. Korea Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 52. Southeast Asia Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 53. India Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 54. Australia Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 55. Europe Therapeutic Nuclear Medicines Sales Market Share by Country in 2020

Figure 56. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country in 2020

Figure 57. Europe Therapeutic Nuclear Medicines Sales Market Share by Type in 2020

Figure 58. Europe Therapeutic Nuclear Medicines Sales Market Share by Application in 2020

Figure 59. Germany Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 60. France Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 61. UK Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 62. Italy Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 63. Russia Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 64. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country in 2020

Figure 65. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country in 2020

Figure 66. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Type in 2020

Figure 67. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Application in 2020

Figure 68. Egypt Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 69. South Africa Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 70. Israel Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 71. Turkey Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 72. GCC Country Therapeutic Nuclear Medicines Revenue Growth 2016-2021 ($ Millions)

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles